What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
His primary scientific interests are in Internal medicine, Psychiatry, Depression, Dementia and Placebo.
His Internal medicine study incorporates themes from Major depressive disorder, Endocrinology, Major depressive episode and Oncology.
His work carried out in the field of Psychiatry brings together such families of science as Alzheimer's disease, Randomized controlled trial and Hostility, Clinical psychology.
His Depression research is multidisciplinary, incorporating perspectives in Anesthesia, Neuropsychology and Comorbidity.
The various areas that he examines in his Dementia study include Neuroscience, Pediatrics and Default mode network.
His research on Placebo also deals with topics like
- Citalopram, which have a strong connection to Reuptake inhibitor,
- Interpersonal psychotherapy that intertwine with fields like Maintenance therapy,
- Pharmacotherapy which connect with Clinical trial.
His most cited work include:
- Mood disorders in the medically ill: scientific review and recommendations. (816 citations)
- Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression: A Randomized Controlled Trial in Patients Older Than 59 Years (537 citations)
- The nature and determinants of neuropsychological functioning in late-life depression. (467 citations)
What are the main themes of his work throughout his whole career to date?
Bruce G. Pollock spends much of his time researching Psychiatry, Internal medicine, Depression, Pharmacology and Dementia.
The study incorporates disciplines such as Placebo, Randomized controlled trial and Clinical psychology in addition to Psychiatry.
His studies in Internal medicine integrate themes in fields like Endocrinology and Schizophrenia, Antipsychotic.
His research links Pharmacotherapy with Depression.
His research on Dementia frequently links to adjacent areas such as Alzheimer's disease.
His work focuses on many connections between Nortriptyline and other disciplines, such as Anesthesia, that overlap with his field of interest in Dosing.
He most often published in these fields:
- Psychiatry (44.63%)
- Internal medicine (45.19%)
- Depression (24.07%)
What were the highlights of his more recent work (between 2014-2021)?
- Psychiatry (44.63%)
- Dementia (21.85%)
- Disease (9.81%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Psychiatry, Dementia, Disease, Internal medicine and Cognition.
His research in Psychiatry intersects with topics in Young adult, Alzheimer s dementia and Placebo.
Bruce G. Pollock interconnects Alzheimer's disease, Major depressive disorder, Audiology and Psychosocial in the investigation of issues within Dementia.
His research in Internal medicine intersects with topics in Endocrinology, Oncology, Positron emission tomography, Pharmacology and Antipsychotic.
His Antipsychotic study also includes fields such as
- Anesthesia and related Pharmacokinetics,
- Randomized controlled trial and related Physical therapy.
His Cognition research is multidisciplinary, incorporating elements of Schizophrenia, Neuroimaging and Clinical psychology.
Between 2014 and 2021, his most popular works were:
- Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study (88 citations)
- Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study (88 citations)
- Extent of Dorsolateral Prefrontal Cortex Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease. (49 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
Bruce G. Pollock mainly investigates Psychiatry, Dementia, Internal medicine, Pharmacology and Cognition.
Bruce G. Pollock has included themes like Young adult, Placebo and Randomized controlled trial in his Psychiatry study.
His biological study spans a wide range of topics, including Alzheimer's disease, Audiology and Risk factor.
His work deals with themes such as Extrapyramidal symptoms, Antipsychotic, Dopamine receptor D2, Olanzapine and Antidepressant, which intersect with Pharmacology.
His work carried out in the field of Olanzapine brings together such families of science as Risperidone and Pharmacokinetics.
His Cognition study integrates concerns from other disciplines, such as Schizophrenia, Neuroimaging, Oncology and Clinical psychology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
